Indeed, carriers of BRCA2 mutations exhibit a 3.5–5.8-fold increased risk of developing pancreatic cancer compared to the general population, and mutations in the BRCA1 gene, encoding a crucial protein involved in DNA repair, are also associated with an elevated risk of pancreatic cancer. This evidence concerns the gene BRCA2 and pancreatic neoplasm.